Resultados: 4

    AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s Disease

    Gastroenterology; 6 (165), 2023
    Biomarkers are used frequently for evaluation and monitoring of patients with Crohn’s disease (CD). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of CD. A multidisciplinary panel of content ...

    AGA clinical practice update on risk stratification for colorectal cancer screening and post-polypectomy surveillance: expert review

    Gastroenterology; 165 (5), 2023
    Since the early 2000s, there has been a rapid decline in colorectal cancer (CRC) mortality, due in large part to screening and removal of precancerous polyps. Despite these improvements, CRC remains the second leading cause of cancer deaths in the United States, with approximately 53,000 deaths projected...

    AGA clinical practice update on the epidemiology, evaluation, and management of exocrine pancreatic insufficiency: expert review

    Gastroenterology; 165 (5), 2023
    Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the pancreas to deliver a minimum/ threshold level of specific pancreatic digestive enzymes to the intestine, leading to the maldigestion of nutrients and macronutrients, resulting in their variable deficiencies. EPI is freque...

    AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis

    Gastroenterology; 164 (3), 2023
    Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the managemen...